Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization

Annals of Surgical Oncology

Volumn 20, Issue 3, 2013, Pages 923-928

  McNally, Megan E ^a   Martinez, Antonio ^b   Khabiri, Hooman ^a   Guy, Gregory ^a   Michaels, Anthony J ^a   Hanje, James ^a   Kirkpatrick, Robert ^a   Bloomston, Mark ^a   Schmidt, Carl R ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; IOXAGLIC ACID; MITOMYCIN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD CELL COUNT; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CLINICAL ASSESSMENT TOOL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LIVER NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84875231992     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2639-1     Document Type: Article

References (25)

1. DM Parkin F Bray J Ferlay P Pisani 2001 Estimating the world cancer burden: GLOBOCAN, 2000 Int J Cancer. 94 153 156 11668491 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D
2. SF Altekruse KA McGlynn ME Reichman 2009 Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol. 27 1485 1491 19224838 10.1200/JCO.2008.20.7753
3. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gasroenterology. 132 2557 2576 10.1053/j.gastro.2007. 04.061 1:CAS:528:DC%2BD2sXnvFOgsrw%3D
4. JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet. 362 1907 1917 14667750 10.1016/S0140-6736(03)14964-1
5. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology. 37 429 442 12540794 10.1053/jhep.2003.50047 1:CAS:528: DC%2BD3sXhsFeltrg%3D
6. CK Tan NM Law HS Ng D Machin 2003 Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation J Clin Oncol. 21 2294 2298 12805329 10.1200/JCO.2003.03.151
7. M Schoniger-Hekele C Muller M Kutilek C Oesterreicher P Ferenci A Gangl 2001 Hepatocellular carcinoma in Central Europe: prognostic features and survival Gut. 48 103 109 11115830 10.1136/gut.48.1.103 1:CAS:528: DC%2BD3MXntFKmug%3D%3D
8. J Bruix JM Llovet 2002 Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology. 35 519 524 11870363 10.1053/jhep.2002.32089
9. CS Roxburgh DC McMillan 2010 Role of systemic inflammatory response in predicting survival in patients with primary operable cancer Future Oncol. 6 149 163 20021215 10.2217/fon.09.136 1:CAS:528:DC%2BD1MXhsFyitL3P
10. MR Jung YK Park O Jeong, et al. 2011 Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection of late stage gastric cancer J Surg Oncol. 104 504 510 21618251 10.1002/jso.21986
11. B Azab VR Bhatt J Phookan, et al. 2012 Usefulness of the neutrophil-to-lymphocyte ration in predicting short- and long-term mortality in breast cancer patients Ann Surg Oncol. 19 217 224 21638095 10.1245/s10434-011- 1814-0
12. N Kobayashi S Usui S Kikuchi, et al. 2012 Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer Lung Cancer. 75 223 227 21764477 10.1016/j.lungcan.2011.06.009
13. HY Hung JS Chen CY Yeh, et al. 2011 Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy Int J Colorectal Dis. 26 1059 1065 21479566 10.1007/s00384-011-1192-x
14. TM Chen CC Lin PT Huang CF Wen 2012 Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation J Gastroenterol Hepatol. 27 553 561 21913982 10.1111/j.1440-1746.2011.06910.x 1:CAS:528:DC%2BC38XltlaksLY%3D
15. KJ Halazun MA Hardy AA Rana, et al. 2009 Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma Ann Surg. 250 141 151 19561458 10.1097/SLA. 0b013e3181a77e59
16. D Gomez S Farid HZ Malik, et al. 2008 Preoperative neutrophil-to- lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg. 32 1757 1762 18340479 10.1007/s00268-008-9552-6 1:STN:280:DC%2BD1cvotlegtA%3D%3D
17. R Zahorec 2001 Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill Bratisl Lek Listy. 102 5 14 11723675 1:STN:280:DC%2BD3Mnnsl2mtg%3D%3D
18. J Bruix M Sherman JM Llovet, et al. 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol. 35 421 430 11592607 10.1016/S0168-8278(01)00130-1 1:STN:280:DC%2BD3MrksFCmtg%3D%3D
19. V Mazzaferro E Regalia R Doci 1966 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med. 334 693 699 10.1056/NEJM199603143341104
20. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow Lancet. 357 539 545 11229684 10.1016/S0140-6736(00)04046-0 1:CAS:528: DC%2BD3MXhsVKltb0%3D
21. A Satomi S Murakami K Ishida M Mastuki T Hashimoto M Sonoda 1995 Significance of increased neutrophils in patients with advanced colorectal cancer Acta Oncol. 34 69 73 7532422 10.3109/02841869509093641 1:STN:280:DyaK2M7mvFCitA%3D%3D
22. H Schmidt S Suciu CJ Punt, et al. 2007 Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American joint committee on cancer stage IV melanoma: results of the EORTC 18951 Biochemotherapy trial J Clin Oncol. 25 1562 1569 17443000 10.1200/JCO.2006.09.0274 1:CAS:528:DC%2BD2sXlsVynur0%3D
23. F Donskov KM Bennedsgaard M Hokland, et al. 2004 Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma Cancer Immunol Immunother. 53 729 739 15088127 10.1007/s00262-004-0525-9 1:CAS:528:DC%2BD2cXltF2hsrk%3D
24. VR Bertuzzo M Cescon M Ravaioli, et al. 2011 Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers Transplantation. 91 1279 1285 21617590 10.1097/TP.0b013e3182187cf0
25. ZL Huang J Luo M Chen JQ Li M Shi 2011 Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization J Vasc Interv Radiol. 22 702 709 21514523 10.1016/j.jvir.2010.12.041